U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07565441) titled 'Drug-Drug Interactions of JMKX003142 in Healthy Participants' on April 27.
Brief Summary: This is a single-center, non-randomized, open-label, self-controlled, Phase I clinical trial to evaluate the drug-drug interactions (DDI) of JMKX003142 tablets in healthy adult participants.
The study consists of five cohorts (Cohorts 1, 2, 3, 4, and 5). A total of 24 participants are planned enrollment in each of Cohorts 1, 2, 3, and 5, while 16 participants are planned for Cohort 4.
Study Start Date: May 11
Study Type: INTERVENTIONAL
Condition:
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Intervention:
DRUG: JMKX003142 tablets
3...